TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013
TCL Archive Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival December 27, 2013
TCL Archive NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis” May 7, 1993